共 50 条
- [1] In Vitro Activity of Imipenem-Relebactam Alone or in Combination with Amikacin or Colistin against Pseudomonas aeruginosaANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (09)Asempa, Tomefa E.Nicolau, David P.Kuti, Joseph L.
- [2] Imipenem/Cilastatin/Relebactam Alone and in Combination against Pseudomonas aeruginosa in the In Vitro Pharmacodynamic ModelANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (12)Chen, Iris H.Nicolau, David P.Kuti, Joseph L.
- [3] In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosaBMC MICROBIOLOGY, 2019, 19 (1)Young, KatherinePainter, Ronald E.Raghoobar, Susan L.Hairston, Nichelle N.Racine, FredWisniewski, DouglasBalibar, Carl J.Villafania, ArtjohnZhang, RuminSahm, Daniel F.Blizzard, TimothyMurgolo, NicholasHammond, Milton L.Motyl, Mary R.
- [4] In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosaBMC Microbiology, 19Katherine YoungRonald E. PainterSusan L. RaghoobarNichelle N. HairstonFred RacineDouglas WisniewskiCarl J. BalibarArtjohn VillafaniaRumin ZhangDaniel F. SahmTimothy BlizzardNicholas MurgoloMilton L. HammondMary R. Motyl
- [5] Comparison of In Vitro Activity of Ceftazidime-Avibactam and Imipenem-Relebactam against Clinical Isolates of Pseudomonas aeruginosaMICROBIOLOGY SPECTRUM, 2023, 11 (03):Wang, LeileiZhang, XuefeiZhou, XunYang, FanGuo, QinglanWang, Minggui
- [6] In vitro activity of imipenem-relebactam alone and in combination with fosfomycin against carbapenem-resistant gram-negative pathogensDIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2022, 103 (03)Xu, ChunquanChen, TaoZhang, SiqinZhou, CuiLiao, WenliFang, RenchiChen, LijiangZhou, Tieli
- [7] IN VITRO ACTIVITY OF IMIPENEM/RELEBACTAM AGAINST PSEUDOMONAS AERUGINOSA ISOLATES FROM US HOSPITALSCRITICAL CARE MEDICINE, 2019, 47Asempa, TomefaNicolau, DavidKuti, Joseph
- [8] In vitro postantibiotic effect of imipenem and enoxacin alone in combination against Pseudomonas aeruginosaPHARMAZIE, 1997, 52 (07): : 544 - 546Hostacka, A
- [9] Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and lsogenic β-Lactam-Resistant MutantsANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (02)Fraile-Ribot, Pablo A.Zamorano, LauraOrellana, Rociodel Barrio-Tofino, EsterSanchez-Diener, IrinaCortes-Lara, SaraLopez-Causape, CarlaCabot, GabrielBou, GermanMartinez-Martinez, LuisOliver, AntonioGalan, FatimaGracia, IreneAntonio Rodriguez, ManuelMartin, LinaManuel Sanchez, JuanVinuela, LauraVictoria Garcia, MaAntonio Lepe, JoseAznar, JavierLopez-Hernandez, InmaSeral, CristinaJavier Castillo-Garcia, FranciscoIsabel Lopez-Calleja, AnaAspiroz, Carmende la Iglesia, PedroRamon, SusanaRiera, ElenaCruz Perez, MariaGallegos, CarmenCalvo, JorgeDolores Quesada, MariaMarco, FrancescHoyos, YannickPablo Horcajada, JuanLarrosa, NievesJose Gonzalez, JuanTubau, FeCapilla, SilviaOlga Perez-Moreno, MarJose Centelles, MaPadilla, EmmaRivera, AlbaMirelis, BeatrizElisa Rodriguez-Tarazona, RaquelArenal-Andres, Noeliadel Pilar Ortega, MariaMegias, GregoriaGarcia, InmaculadaColmenarejo, Cristina
- [10] In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosisANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023,Ruiz, Victor H.Fratoni, AndrewNicolau, David P.Kuti, Joseph L.